ReviewEmerging infectious diseases
Rhodococcus equi and Arcanobacterium haemolyticum: two "coryneform" bacteria increasingly recognized as agents of human infection.
Review in Emerging infectious diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 93 citations in OpenAlex.
- Article
- Changpingibacter yushuensis gen. nov., sp. nov., isolated from fluvial sediment in Qinghai Tibet Plateau of China.Journal of microbiology (Seoul, Korea) · 2022Article
- Taxonogenomics description ofNew microbes and new infections · 2021Article
- Identification of Genome Sequences of Polyphosphate-Accumulating Organisms by Machine Learning.Frontiers in cell and developmental biology · 2020Article
- Article
- Article
- [Fatal sepsis due to an emerging bacteria: Arcanobacterium hemolyticum].The Pan African medical journal · 2016Article
- Lemierre Syndrome Caused by Arcanobacterium haemolyticum Alone in a Healthy Man.Chonnam medical journal · 2012Article
- Arcanolysin is a cholesterol-dependent cytolysin of the human pathogen Arcanobacterium haemolyticum.BMC microbiology · 2011Article
- Lemierre syndrome caused by co-infection by Arcanobacterium haemolyticum and Fusobacterium necrophorum.Infection · 2010Article
- Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes.Microbiology (Reading, England) · 2010Article
- A hydrogen-bonding network is important for oxidation and isomerization in the reaction catalyzed by cholesterol oxidase.Acta crystallographica. Section D, Biological crystallography · 2009Article
- Phenotypic and genotypic characterization of Arcanobacterium haemolyticum isolates from infections of horses.Journal of clinical microbiology · 2009Article
- Rhodococcus equi infection after alemtuzumab therapy for T-cell prolymphocytic leukemia.Emerging infectious diseases · 2007Article
- Inhibition of CFTR Cl- channel function caused by enzymatic hydrolysis of sphingomyelin.Proceedings of the National Academy of Sciences of the United States of America · 2007Article
- Cavitary Rhodococcus equi pneumonia with endobronchial granulomas: report of an unusual case.Pediatric radiology · 2003Article
- Detection of antibodies against Rhodococcus equi in Alpaca (Lama pacos) in Italy.European journal of epidemiology · 2001Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhodococcus equi and Arcanobacterium haemolyticum, formerly classified in the genus Corynebacterium, are members of the loosely defined taxon "coryneform" bacteria. Although they are the etiologic agents of distinct human infections, both organisms are frequently overlooked, which results in missed or delayed diagnoses. R. equi, long known as an important pathogen of immature horses, has become in the past three decades an opportunistic pathogen of severely immunosuppressed humans. Most cases are secondary to HIV infection. When specifically sought in throat swab cultures, A. haemolyticum is found responsible for 0.5% to 2.5% of bacterial pharyngitis, especially among adolescents. These two microorganisms represent a spectrum of disease in humans: from a mild, common illness to a rare life-threatening infection. Each organism elaborates lipid hydrolyzing enzymes (cholesterol oxidase by R. equi and sphingomyelinase D by A. haemolyticum) that are toxic to animals and humans and damaging to mammalian cell membranes. The participation of the cytotoxins in pathogenicity is discussed. Greater awareness of the properties of these two bacteria may promote faster, more accurate diagnoses and better clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.